Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Jan 2012 for VistaGen Therapeutics, Inc., €87.5M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Allen Easley Cato: trading record in brief
Our data holds just one disclosure by Allen Easley Cato, dated 9 January 2012, reporting a transaction worth €87.5M in VistaGen Therapeutics, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Allen Easley Cato
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 11,363 shares@ US$9,999.44Common StockSEC:0001412678-12-000001:0
1 of 1 declaration